lobbying_activities: 2867414

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2867414	2d84e5ab-64ae-4b65-a296-20bf410fffb1	Q3	BLUESTONE STRATEGIES, LLC	400658980	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2022	third_quarter	PHA	Pharmacy Act; Drug Pricing; Generic Brand Settlement; Generic Dispensing; Generic Biologics; & Specialty Drug Issues. HR 5260 Reduced Cost & Continued Care Act of 2021.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-10-17T11:12:40-04:00